Exscientia AI Limited

Grantee website Oxford, United Kingdom
to rapidly discover and develop potent, orally available, small molecule inhibitors of the main protease (Mpro) of SARS-CoV-2 using artificial intelligence-driven structure guided drug design
Global Health
JUNE 2021
Region served
Committed amount
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
Grantee location
Oxford, United Kingdom

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.